genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Search
About GEN
Contact GEN
Subscribe/Update Preferences
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Bioprocessing
Lonza Plans New Fill & Finish Facility in Stein, Switzerland
Bioprocessing
Harnessing Bacteria to Make Jet Fuel: Not Just An “Explosive Idea?”
Drug Discovery
Potential Therapeutic Treatment for Androgenetic Alopecia
Dengue
Mosquitoes Find Humans Infected with Zika or Dengue Viruses More Attractive
Infectious Diseases
Enteric Viruses Shown Capable of Spreading via Saliva
Insights
All
Trends for 2020
Trends for 2021
Insights
Single-Cell Functional Proteome Profiling Uncovers Novel Targets for Alzheimer’s Disease
Artificial Intelligence
AI Can Make a Difference on the Factory Floor If Biopharma…
Bioprocessing
Separation Technique Adjusted for mRNA Vaccine Boom
Antibodies
Combatting Therapeutic-Protein Aggregation
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
A-Lists
Six of the Best Reports from the Front Line of Biotechnology
A-Lists
Top 10 RNA-Based Biopharmas
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Home
Virology
HIV
HIV
Coronavirus
Dengue
Ebola
HBV
HCV
Herpes
HIV
HPV
Influenza
West Nile Virus
Zika
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
HIV
Common HIV Treatment Improves Cognition in Down Syndrome Mice
HIV
Despite Low Monkeypox Risk, Vaccine Developers Prepare
HIV
Could a One-Shot Treatment for Patients with HIV Be on the Horizon?
HIV
Developing Non-Affinity Purification for HIV and SARS-CoV-2 Vaccines
HIV
ReiThera and Exothera Collaborate on Vaccine Manufacturing Process
HIV
DNA Vaccine for HIV Moves Forward with Tier-2 Neutralization in Mice
HIV
Highly Virulent HIV-1 Variant That Causes Rapid T Cell Decline Discovered...
HIV
mRNA-Based HIV Vaccine Shows Promise in Monkeys
HIV
Technique Solves HIV Capsid Structure; Could Serve as Blueprint for Capsid-Targeting...
HIV
HIV-Infected Cells Evade Immune System by Sugar Molecule
Commentary
Making the Transition from an Academic to a Biobusiness Entrepreneur
HIV
Gene Identified in Mice and Monkeys Acts as Natural Antiviral Against...
HIV
Inflammasome Therapeutics Takes On Sustained Drug Delivery
HIV
HIV, VSV, and Zika Virus Suppression in Just One Protein
HIV
HIV Vaccine Disappointment: Trial Data Show Lack of Sufficient Protection
1
2
3
...
7
Page 1 of 7
Scroll Up
![Sanction was based on study that found the HPV vaccine to be 78% effective.[alexfiodorov-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesDec2010Dec23_2010_10349430_GrayVirusHIV_GardasilApprovedForAnalCancer1148142105-324x160.jpg "DNA Vaccine for HIV Moves Forward with Tier-2 Neutralization in Mice")
![Xpert HIV viral load assay will be made available at concessionary prices to public and non-for-profit providers.[4designersart - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesFeb2011Feb3_2011_22401855_GreenOrangeRedHIV_CepheidFINDhivTestCollab1798021124-2-324x160.jpg "Highly Virulent HIV-1 Variant That Causes Rapid T Cell Decline Discovered in the Netherlands")
